Supriya Lifescience profit jumps 47% in Q4
The pharmaceutical company closed the fiscal year with a 50% revenue surge in the final quarter, reaching ₹276.53 crore.
— 1 earlier story on Supriya Lifescience Ltd. →What's new
- Q4 revenue climbed 50% year-on-year to ₹276.53 crore.
- Full-year revenue reached ₹827.88 crore, an 18.9% increase.
- Board recommended a final dividend of ₹1 per share.
Why this matters
Supriya Lifescience finished the year with a sharp acceleration in its final quarter. The 47% profit growth in Q4 significantly outpaced the 11.3% growth recorded for the full year, suggesting a strong finish to FY26.
What we're watching
- Whether the Q4 growth rate is sustainable in the coming fiscal year.
- Shareholder approval for the proposed dividend.
- Management commentary on the drivers behind the Q4 revenue spike.
The full read
Supriya Lifescience closed FY26 with a surge in its final quarter. Revenue for the period ended March 31, 2026, hit ₹276.53 crore, a 50% increase over the same period last year. Net profit followed a similar trajectory, rising 47% to ₹74.23 crore. These quarterly figures represent a significant acceleration compared to the full-year results, where revenue grew 18.9% to ₹827.88 crore and net profit rose 11.3% to ₹209.12 crore. The board has proposed a final dividend of ₹1 per share, pending shareholder approval. The company's ability to scale its bottom line in the final quarter at a rate far exceeding its annual average is the primary takeaway from these audited results.
Questions answered
- What were the full-year financial results for FY26?
- The company reported annual revenue of ₹827.88 crore and a net profit of ₹209.12 crore.
- How did the fourth quarter compare to the full-year performance?
- The fourth quarter showed stronger momentum with revenue and profit growth of 50% and 47% respectively, compared to full-year growth rates of 18.9% and 11.3%.
- Is there a dividend for shareholders?
- The board has recommended a final dividend of ₹1 per equity share, which remains subject to approval at the next annual general meeting.
Story so far
All notes on SUPRIYA →- 27 May 2026 · 6:55 PM IST Supriya Lifescience profit jumps 47% in Q4
- today Supriya Lifescience ends FY26 with a 50% revenue jump in Q4